To the Editor: Progressive aspergillosis in patients with hematological malignancy and chemotherapy-induced pancytopenia carries a high mortality and remains a contraindication to conventional allogeneic hematopoietic stem cell transplantation (HSCT) with myeloablative chemoradiotherapy.[1-4][1]
No takes yet. Share an insight, caveat, or question.
Xun et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: